Comparing 3 Schedules of Alimta Plus Gemzar
NCT00034606
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
INDUSTRY
Sponsor class
Conditions
Carcinoma, Non-Small-Cell Lung
Lung Neoplasms
Neoplasms
Interventions
DRUG:
Pemetrexed (Alimta) in combination with gemcitabine (Gemzar)
Sponsor
Eli Lilly and Company